Clinical Trial Update: Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD [Phase 3]

View source ↗

Summary

This Phase 3 trial compares photodynamic therapy with intravitreal bevacizumab alone versus the combination of PDT, intravitreal bevacizumab, and triamcinolone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Bevacizumab (bevacizumab)
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Neovascular Age-Related Macular Degeneration | Phase 3 | Status: UNKNOWN